n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime has been researched along with Disease Models, Animal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chatham, JC; Chen, YF; Feng, W; Majid-Hassan, E; Miller, AP; Nöt, LG; Oparil, S; Xing, D; Zhang, Y | 1 |
1 other study(ies) available for n-acetylglucosaminono-1,5-lactone o-(phenylcarbamoyl)oxime and Disease Models, Animal
Article | Year |
---|---|
Increased protein O-GlcNAc modification inhibits inflammatory and neointimal responses to acute endoluminal arterial injury.
Topics: Acetylglucosamine; Animals; Anti-Inflammatory Agents; Carotid Arteries; Carotid Artery Injuries; Disease Models, Animal; Female; Glucosamine; Glycosylation; Inflammation Mediators; Monocytes; Neutrophil Infiltration; Ovariectomy; Oximes; Phenylcarbamates; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Time Factors | 2008 |